Earnings call transcript: AMERISAFE Q2 2025 results show mixed performance

AMERISAFE Inc. (AMSF) reported mixed Q2 2025 results, with EPS of $0.53 and revenue of $79.7 million both narrowly missing analyst estimates. Despite the earnings miss, the stock rose 6.08% in aftermarket trading, propelled by strong operational performance, including a 4.3% increase in gross written premiums, a 93.8% renewal retention rate, and a focus on agent effectiveness. The company emphasized its strong balance sheet, consistent underwriting profitability, and capital management, including a reauthorized share repurchase program and a 10.7% dividend yield, positioning it for stability amidst potential market shifts in loss costs.

Analysis

AMERISAFE Inc. (AMSF) presented a mixed Q2 2025 financial report, characterized by minor misses on headline figures but underpinned by robust operational strength. The company posted an EPS of $0.53 against a $0.55 forecast and revenue of $79.7 million, just shy of the $79.87 million expectation. Despite these misses, the market reacted positively, with the stock climbing 6.08% in after-hours trading. This response was driven by strong underlying performance indicators, including a 4.3% year-over-year increase in gross written premiums and an impressive 12.8% growth in voluntary premiums for policies written in the quarter. A key highlight is the company's ability to grow its policy count by 3.4% while maintaining an exceptional renewal retention rate of 93.8%, all while strategically reducing its agent count to improve efficiency. While net income rose to $14 million from $11 million YoY, net investment income saw a 10.2% decrease due to a smaller asset base following a special dividend. Management acknowledged potential pressure on its 71% accident year loss ratio from moderating industry loss costs but reaffirmed its disciplined underwriting, strong balance sheet, and commitment to capital returns through a newly authorized $25 million share repurchase program and a consistent dividend.

Key Decisions for Investors

• Investors should look past the minor EPS and revenue miss and focus on the strong underlying operational metrics, such as the 12.8% growth in voluntary premiums and 93.8% retention rate, as primary indicators of business health.
• It is prudent to monitor the company's expense ratio and its ability to maintain its 71% accident year loss ratio, as management acknowledged pressures from industry-wide trends in medical severity and declining loss costs.
• Evaluate AMERISAFE based on its total shareholder return profile, which is heavily supported by a significant dividend yield and an active $25 million share repurchase program, offering a compelling case for income and value-oriented portfolios.
• Given the stock's low beta of 0.38, investors seeking defensive positions with lower market volatility may find the company's demonstrated stability and consistent underwriting profitability attractive.